Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Sep 17, 2014 (12 years ago)

Xarelto (rivaroxaban)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Microbial Contamination of Non-Sterile Products: Consumer complaint confirmed microbial contamination in sales sample.

Cause type: Microbial contamination

Bacteria, mold, yeast or other microorganisms detected in the product. Contamination can occur from water systems, equipment or handling, and can cause infection. All microbial contamination recalls.

What was recalled

Xarelto (rivaroxaban) Tablets 15 mg per tablet, 5 count bottle, Rx Only, Manufactured by: JOLLC, Gurabo, PR 00778 NDC 50458-578-99

Affected NDC 50458-0578-99

Compare with the code on your package — it is the most precise check available.

Drug: Rivaroxaban

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Xarelto
rivaroxaban
NDC 50458-0578
15 mg/1 Tablet, Film Coated
Oral
Janssen Pharmaceuticals, Inc. Rx
Recalling firm
Janssen Ortho L.L.C.
NDC code
50458-578-99
Origin
PR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0006-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Rivaroxaban recalls

See all
Class II · Moderate risk

Rivaroxaban active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-882-2015
Class II · Moderate risk

RIVAROXABAN Tablet

Labeling: Label Mixup; RIVAROXABAN Tablet, 20 mg may be potentially mislabeled as VENLAFAXINE HCL, Tablet, 100 mg, NDC 00093738301, Pedigree: W002619, EXP: 6/4/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-596-2014

Other recalls by Janssen Ortho L.L.C.

All 2014 recalls
Class III · Low risk

Invokamet (canagliflozin and metformin HCl)

Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.

Terminated Labeling / mix-up Janssen Ortho L.L.C. NDC 50458-543-60 D-0115-2017

Other microbial contamination recalls from 2014

All microbial contamination recalls
Class II · Moderate risk

CVS pharmacy

Microbial Contamination of Non-Sterile Products: CVS Pharmacy Pain Relieving Antiseptic Spray tested positive for microbial growth.

Terminated Microbial contamination Wisconsin Pharmacal Company NDC 68093-6150-1 D-0047-2015